COPENHAGEN (Reuters) – Danish biotechnology company Bavarian Nordic expects to sign more contracts for its vaccine against monkeypox after “overwhelming interest” from governments around the world, its chief financial officer told investors on Tuesday.
(Reporting by Nikolaj Skydsgaard; Editing by David Goodman)
